How should Florastor (Saccharomyces boulardii) be dosed during and after a long‑term course of Augmentin (amoxicillin‑clavulanate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Florastor Dosing During and After Long-Term Augmentin

Start Florastor (Saccharomyces boulardii) 250 mg twice daily immediately when beginning Augmentin, continue throughout the entire antibiotic course, and extend for an additional 7 days after completing antibiotics to optimize microbiota recovery.

Dosing Regimen

  • During Augmentin treatment: Saccharomyces boulardii 250 mg (1 capsule) twice daily
  • After Augmentin completion: Continue for 7 additional days at the same dose
  • Timing: Begin on day 1 of antibiotic therapy (within 48 hours at latest for optimal efficacy)
  • Administration: Can be taken with or without food; no interaction with the antibiotic itself since S. boulardii is a yeast and unaffected by antibacterial agents 1

Evidence-Based Rationale

The evidence strongly supports this approach for amoxicillin-clavulanate (Augmentin) specifically:

During antibiotic treatment, S. boulardii directly mitigates dysbiosis by:

  • Stabilizing bacterial biomass and preserving metabolic functions 2
  • Reducing overgrowth of pathogenic Escherichia and Enterobacter species 3
  • Maintaining production of beneficial metabolites like propionate and indole-3-propionic acid 2
  • Significantly reducing antibiotic-associated diarrhea (RR 0.36 for diarrhea specifically) 1

The extended 7-day post-antibiotic course is critical because:

  • Microbiota disruption persists for weeks after antibiotics stop 3
  • The additional week accelerates restoration of beneficial anaerobes, particularly the Clostridium coccoides group 4
  • Studies demonstrate that 17 total days of S. boulardii (10 days during + 7 days after a typical antibiotic course) enhances return to baseline bacterial equilibrium 5
  • Without extended dosing, microbiota alterations remain incompletely restored 2 weeks post-antibiotics 3

Clinical Benefits

Multiple high-quality studies with amoxicillin-clavulanate specifically show:

  • Reduced adverse events: Better tolerability of the antibiotic regimen 3
  • Lower diarrhea rates: 6.9% vs 15.6% without S. boulardii (p=0.007) 6
  • Faster microbiota recovery: Accelerated restoration of Clostridium coccoides and Bacteroides groups 4
  • Reduced inflammation: Decreased pro-inflammatory cytokine secretion in immune cells exposed to S. boulardii-modulated microbiota 2

Important Caveats

  • Dose matters: Studies used 500 mg/day (250 mg twice daily). Lower doses may be ineffective 7
  • Timing is critical: Start within 48 hours of antibiotic initiation for maximum benefit 1
  • Strain-specific: This recommendation applies specifically to S. boulardii CNCM I-745 (the Florastor strain), not other probiotics 1
  • Safety profile: Excellent safety record with no significant adverse events in clinical trials 3, 6

The 2020 AGA guidelines 8 note insufficient evidence to make broad probiotic recommendations for most conditions, but the specific combination of S. boulardii with amoxicillin-clavulanate has robust, consistent evidence from multiple randomized controlled trials demonstrating both efficacy and safety.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.